Question

In: Statistics and Probability

In a clinical trial, 50 patients who received a new medication are randomly selected. It was...

In a clinical trial, 50 patients who received a new medication are randomly selected. It was found that 10 of them suffered serious side effects from this new medication. Let p denote the population proportion of patients suffered serious side effects from this new medication.

Find the minimum sample size needed to estimate the population proportion p with 90% confidence such that the estimate is accurate within 0.04 of p.

Solutions

Expert Solution

sample proportion ,   p̂ =10/50 = 0.2                          
sampling error ,    E =   0.04                          
Confidence Level ,   CL=   0.90                          
                                  
alpha =   1-CL =   0.10                          
Z value =    Zα/2 =    1.645   [excel formula =normsinv(α/2)]                      
                                  
Sample Size,n = (Z / E)² * p̂ * (1-p̂) = (   1.645   /   0.04   ) ² *   0.20   * ( 1 -   0.20   ) =    270.55
                                  
                                  
so,Sample Size required=       271                          


Related Solutions

In a clinical trial, 50 patients who received a new medication are randomly selected. It was...
In a clinical trial, 50 patients who received a new medication are randomly selected. It was found that 10 of them suffered serious side effects from this new medication. let p denote the population proportion of patients suffered serious side effects from this new medication. The 90% confidence interval for p is about
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain...
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain in patients undergoing total knee replacement surgery. In the trial, patients are randomly assigned to receive either the new medication or the standard medication. After receiving the assigned medication, patients are asked to report their pain on a scale of 0-100 with higher scores indicative of more pain. Data on the primary outcome are shown below. Sample Size Mean Pain Score Standard Deviation of...
You are designing a randomized clinical trial of a new anti-hypertensive medication. The goal is to...
You are designing a randomized clinical trial of a new anti-hypertensive medication. The goal is to lower the incidence of stroke, but a surrogate endpoint will be used instead of stroke as the primary endpoint of the trial. (1) Give an example of a surrogate endpoint that makes sense for the context of this clinical trial. (2) In the context of this trial, give a rationale for why an investigator might decide to use a surrogate endpoint.
The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly...
The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly assigned to receive either ancrod or a placebo. One of the response variables in the study was whether or not the subjects experienced intracranial hemorrhaging. Of the 84 patients who received ancrod, 13 hemorrhaged. Of the 77 patients who received the placebo, only three hemorrhaged. a.Is there a significant difference in hemorrhaging rates between treatments? Show your work and include all steps for full...
A clinical trial is conducted to test a new medication designed to lower systolic blood pressure...
A clinical trial is conducted to test a new medication designed to lower systolic blood pressure (SBP). Participants are randomly assigned to receive the new medication or a placebo. The outcome is clinically significant SBP reduction after 30 days. The data are shown below. Compute the totals. Significant Reduction in SBP No Significant Reduction in SBP Total New Medication 44 76 Placebo 21 99 Total Compute the proportion of participants who experienced a significant reduction in SBP, given they received...
Patients in a clinical trial for a new cancer treatment are classified as permanently cured, in remission
Patients in a clinical trial for a new cancer treatment are classified as permanently cured, in remission (the cancer is present, but not growing), sick (the cancer is growing), or deceased. After one year of treatment, 1/3 of sick patients go into remission, another 1/3 are permanently cured, and, unfortunately, 1/3 are deceased. Patients in remission also receive treatment after a year of which 1/4 remain in remission, 1/2 are permanently cured, and 1/4 decline to the sick condition (a) Formulate...
Researchers conducting a clinical trial randomly assigned 60 patients with painful knee osteoarthritis evenly into one...
Researchers conducting a clinical trial randomly assigned 60 patients with painful knee osteoarthritis evenly into one of three treatment groups: glucosamine, chondroitin, or placebo.After the study period, patients were asked if they experienced substantial improvement in pain and ability to function normally.Thirty-four patients replied that they did have an improvement, including 13 in the glucosamine group, 16 in the chondroitin group, and 5 in the placebo group. List a potential confounding variable for this study and briefly explain a possible...
A clinical trial evaluates a new compound designed to improve wound healing in trauma patients. The...
A clinical trial evaluates a new compound designed to improve wound healing in trauma patients. The new compound is compared against a placebo. After treatment for 5 days with the new compound or placebo, the extent of wound healing is measured. See chart below: Wound Healing by Treatment Percent of Wound Healing Treatment 0-25 26-50 51-75 76-100 New Compound (n=125) 15 37 32 41 Placebo (n=125) 36 45 34 10 Is there a difference in the extent of wound healing...
A clinical trial evaluates a new compound designed to improve wound healing in trauma patients. The...
A clinical trial evaluates a new compound designed to improve wound healing in trauma patients. The new compound is compared against a placebo. After treatment for 5 days with the new compound or placebo, the extent of wound healing is measured and the data are shown in table 7-51. Is there a difference in the extent of wound healing by treatment? Run the appropriate test at a 5% level of significance. (Hint : Are treatment and the percent of wound...
In a trial of 300 patients who received 10-mg doses of a drug daily, 54 reported...
In a trial of 300 patients who received 10-mg doses of a drug daily, 54 reported headaches as a side effect. Construct a 99% confidence interval for the population proportion of patients who receive the drug and report headache as a side effect.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT